LFCS is a part of the MEDALIS "Laboratories of Excellence" (LabEx). This project was selected by French government following a call for proposals aimed at funding internationally recognised laboratories enabling them to compete with their foreign counterparts, to attract internationally renown researchers and lecturers, and to build an integrated policy for high level research, training and development.
The aim of MEDALIS is to harness the existing academic research and entrepreneurial expertise of the consortium and to create a new drug discovery and development centre for cancer and inflammation.
MEDALIS consortium includes Sylviane Muller, Andrew Griffiths, Didier Rognan, Jean-Serge Remy, Frédéric Simonin, Canan Nebigil- Desaubry, Marcel Hibert, Alain Wagner, Valérie Schreiber, and Dominique Bagnard.
MEDALIS will work towards commercialising their research with other locally based technology transfer partners:
• Strasbourg University’s technology development and transfer office
• BioValley Alsace
• Regio Alsace
• Conectus
• SEMIA
The aim of MEDALIS is to harness the existing academic research and entrepreneurial expertise of the consortium and to create a new drug discovery and development centre for cancer and inflammation.
MEDALIS consortium includes Sylviane Muller, Andrew Griffiths, Didier Rognan, Jean-Serge Remy, Frédéric Simonin, Canan Nebigil- Desaubry, Marcel Hibert, Alain Wagner, Valérie Schreiber, and Dominique Bagnard.
MEDALIS will work towards commercialising their research with other locally based technology transfer partners:
• Strasbourg University’s technology development and transfer office
• BioValley Alsace
• Regio Alsace
• Conectus
• SEMIA